Company Filing History:
Years Active: 2013
Title: Innovations of Sang iL Lee in Amyloid-Related Disease Treatment
Introduction
Sang iL Lee is a notable inventor based in Cheonan-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of amyloid-related diseases. His innovative work has the potential to impact the lives of many individuals suffering from conditions such as Alzheimer's disease.
Latest Patents
Sang iL Lee holds a patent for a composition aimed at treating or preventing amyloid-related diseases, which includes 4-O-methylhonokiol as an active ingredient. This pharmaceutical composition has been disclosed as effective for conditions such as Alzheimer's disease, cognitive disorders, and defective memory. The invention highlights the ability of 4-O-methylhonokiol to inhibit the production of β-amyloid, a key factor in the progression of these diseases. Through various animal tests, including the water maze test and passive avoidance test on mice, the efficacy of this composition has been confirmed.
Career Highlights
Sang iL Lee is associated with Bioland Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in treating serious cognitive disorders. The innovative nature of his research positions him as a key figure in the pharmaceutical industry.
Collaborations
Sang iL Lee has collaborated with notable colleagues, including Ki Ho Kim and Ki Soo Kim. Their combined expertise contributes to the ongoing research and development of effective treatments for amyloid-related diseases.
Conclusion
Sang iL Lee's contributions to the field of pharmaceuticals, particularly through his patent on 4-O-methylhonokiol, represent a significant advancement in the treatment of amyloid-related diseases. His work continues to inspire further research and innovation in this critical area of healthcare.